SS&C Technologies (SSNC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Executive summary
Achieved record 2025 performance with GAAP revenue of $6.27B, adjusted EBITDA of $2.46B, and adjusted EPS of $6.14, reflecting strong growth and operational execution.
Returned over $1B to shareholders via buybacks and paid $253.8M in dividends, while reducing net leverage to 2.8x and completing the Calastone acquisition.
Continued significant investment in AI, R&D, and sales/marketing, positioning for future growth in financial services and healthcare.
Engaged with 13 of top 20 shareholders, representing 53% of outstanding shares (excluding CEO holdings), to inform governance and compensation practices.
Voting matters and shareholder proposals
Four proposals: elect three Class I directors, advisory vote on executive compensation, ratify PwC as auditor for 2026, and approve the Third Amended and Restated 2023 Stock Incentive Plan.
Board recommends voting FOR all proposals.
Shareholders can vote online, by phone, mail, or during the virtual meeting.
Board of directors and corporate governance
Board consists of eight members, 88% independent, with a classified structure and mandatory retirement age of 75.
Lead Independent Director role maintained; board committees (Audit, Compensation, Nominating/Governance) are fully independent.
Annual board and committee self-evaluations, majority voting for directors, and robust director nomination process.
Succession planning and overboarding policies in place; directors expected to limit service on other boards.
Latest events from SS&C Technologies
- Virtual annual meeting to vote on directors, pay, auditor, and stock plan; board recommends approval.SSNC
Proxy filing8 Apr 2026 - AI-driven growth, high margins, and disciplined acquisitions fuel strong financial outlook.SSNC
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - AI-driven efficiency, disciplined growth, and strategic acquisitions fuel robust margins and retention.SSNC
UBS Financial Services Conference 20269 Feb 2026 - Record revenue, double-digit EPS growth, and robust 2026 outlook with strong cash flow.SSNC
Q4 20255 Feb 2026 - Q2 2024 saw 6.5% revenue growth, 45.6% higher net income, and a $1B buyback program.SSNC
Q2 20242 Feb 2026 - Restructured verticals, margin gains from Blue Prism, and healthcare growth via DomaniRx partnership.SSNC
2024 RBC Capital Markets Financial Technology Conference1 Feb 2026 - Strong recurring revenue and margin growth expected, driven by technology and efficiency gains.SSNC
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 4–8% organic growth outlook driven by platform integration, AI, and cross-sell initiatives.SSNC
Analyst Day 202420 Jan 2026 - Q3 2024 delivered 7.3% revenue growth, Battea acquisition, and strong capital deployment.SSNC
Q3 202418 Jan 2026